Carregant...
CD4 cell response to interval therapy with natalizumab
Natalizumab treatment alters peripheral CD4 cells counts in multiple sclerosis (MS) patients, providing a way to monitor the pharmacodynamic effects of the drug. The study was undertaken to assess whether CD4 cell counts correlate with different phases of natalizumab treatment of relapsing MS patien...
Guardat en:
| Publicat a: | Ann Clin Transl Neurol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BlackWell Publishing Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4435710/ https://ncbi.nlm.nih.gov/pubmed/26000328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.190 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|